US EditionPublished • loading... • Updated
Palvella Therapeutics Announces Pricing of Upsized Public Offering
Summary by Hastings Tribune
2 Articles
2 Articles
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ('Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments...
·Manila, Philippines (the)
Read Full Article
Palvella Therapeutics Announces Pricing of Upsized Public Offering
WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there…
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
